18F-Fluciclovine PET/MRI in a patient with squamous cell carcinoma of the uterine cervix correlated with 18F-FDG PET/CT

Nghi C. Nguyen, Chan Hong Moon, Sushil Beriwal

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

A 32-year-old woman with a FIGO (International Federation of Gynecology and Obstetrics) stage IIA invasive squamous cell carcinoma of the uterine cervix underwent a clinical FDG PET/CT scan, which revealed intense uptake in the primary. On research 18F-fluciclovine PET/MRI, the primary showed elevated fluciclovine uptake at 5 and 40 minutes after radiotracer injection, with no evidence of regional or distant metastasis. Fluciclovine PET may have diagnostic value for cervical cancer imaging with a potential advantage over FDG of minimal urinary activity from renal excretion; however, in this patient, the metabolic activity was inferior to that of FDG PET.

Original languageEnglish (US)
Pages (from-to)802-804
Number of pages3
JournalClinical nuclear medicine
Volume45
Issue number10
DOIs
StatePublished - 2020
Externally publishedYes

Keywords

  • F-FDG
  • F-fluciclovine
  • PET/CT
  • PET/MRI
  • uterine cancer

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of '18F-Fluciclovine PET/MRI in a patient with squamous cell carcinoma of the uterine cervix correlated with 18F-FDG PET/CT'. Together they form a unique fingerprint.

Cite this